We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- To divide or not to divide?
- Cancer: a cell that keeps dividing
- Normal cell cycle phases: overview
- Why care about proliferative control?
- Hallmarks of cancer
- Normal cell cycle phases: loss of control
- Mitogenic signals: G1 checkpoint
- G1 checkpoint: proliferative and anti-proliferative signals
- Cancer cells ignore G1 checkpoint signals
- G1 checkpoint: proliferative control
- Proliferative control: receptors and ligands
- Proliferative controls: transit workers
- Controls: cell motor machinery (motors)
- Oncogenic funnel
- Passing the signal along
- Cyclins and cyclin dependent kinases (CDKs)
- Passing the signal along: phosphorylation
- The cyclin-CDK 'relay race': expression level control
- Wave-like expression of cyclins
- Waves of cyclin - waves of CDK
- The cyclin 'relay race'
- Two ways that cyclins are degraded: SCF
- Two ways that cyclins are degraded: APC-mediated
- The cyclin-CDK 'relay race': phosphorylation
- Cyclin-CDK regulation via phosphorylation: CAK
- Cyclin-CDK regulation via phosphorylation: Cdc25
- The cyclin-CDK 'relay race': stochiometric inhibition
- Anti-proliferative signals induce CDK inhibitors (Ink4 and Cip/Kips)
- TGF-beta induces Ink4 to inhibit in G1 phase
- Cell:cell contact induces p27 to inhibit in G1 phase
- p27: activator or inhibitor of cyclin D-CDK4
- Why the dual role of p27?
- Concerted inhibition of CDK4 and CDK2: INK4
- Concerted inhibition of CDK4 and CDK2: loss of cyclin D
- How does E-K2 break free from p27's inhibition?
- Phosphorylation of p27
- Mitogenic signals: cyclin D-CDK4
- Cyclin D-CDK4 activation: the first step
- Retinoblastoma protein: master G1 checkpoint protein
- The effect of phosphorylated Rb
- Rb exists in several different phosphorylation states
- G1 passage into S phase
- Cell cycle arrest
- Thank you for listening
Topics Covered
- Normal cell cycle phases
- Hallmarks of cancer
- Proliferative and antiproliferative signals
- Oncogenic funnel
- Cyclins and CDKs
- Mitogenic signals
- Retinoblastoma protein
- Mitosis
- Cell arrest
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Blain, S. (2023, March 30). The mammalian cell cycle: the responsive stage of the cell cycle [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 3, 2024, from https://doi.org/10.69645/WHCB6262.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Stacy Blain is the co-founder and an equity holder in Concarlo Therapeutics, Inc, which is developing therapies based on cell cycle regulation.
The mammalian cell cycle: the responsive stage of the cell cycle
Published on March 30, 2023
39 min
Other Talks in the Series: The Molecular Basis of Cancer
Transcript
Please wait while the transcript is being prepared...
0:00
Hi. I'm Dr. Stacy Blain
from SUNY Downstate
Health Science Center.
The topic of today's talk is
the mammalian cell cycle.
0:11
While we have many different
cells in our body,
we have liver cells
that do liver things,
and breast cells that
do breast things,
the one commonality
between all of these cells
is their ability to regulate
their proliferation.
These cells have to
decide when they make
a duplicate copy of
themselves or alternatively,
whether they remain in a
quiet or quiescent state.
Some cells in our body are
dividing all the time.
These would be our skin cells
and members of our GI tract.
These cells are very
short-lived and there needs
to be a constant
birthing of new cells.
Some cells will only
divide when they
receive the appropriate
signals from
their extracellular
environment, such as
our liver cells, or members of
our hematopoietic lineages.
When our livers gets damaged,
those cells can exit
that quiet state,
make a duplicate copy,
restore the liver to
the appropriate size,
and then re-enter
that quiescent state.
Some of our cells have
the ability to divide
but do not divide.
These might be members of
our cardiac lineages or
a neuronal lineages,
and they live in that long-term
quiescent state for decades.
This process of deciding when to
divide or not is all
important and it
help to ensure the integrity of
the organs, as well as the
size and the functionality.
This decision to divide,
which is constant,
happens every second,
every day in all of
our cells, is regulated
by this balance
between proliferative go signals
and anti-proliferative
stop signals.